37.78
-0.03 (-0.08%)
| Previous Close | 37.81 |
| Volume | 2,232,795 |
| Price / Earnings (Forward) | 17.03 |
| Price / Sales | 1.01 |
| Price / Book | 1.70 |
| 52 Weeks Range |
| Profit Margin | 5.94% |
| Operating Margin (TTM) | 10.19% |
| Diluted EPS (TTM) | 2.04 |
| Quarterly Revenue Growth (YOY) | 0.30% |
| Quarterly Earnings Growth (YOY) | -89.00% |
| Total Debt/Equity (MRQ) | 74.09% |
| Current Ratio (MRQ) | 1.35 |
| Operating Cash Flow (TTM) | 462.46 M |
| Levered Free Cash Flow (TTM) | -276.20 M |
| Return on Assets (TTM) | 5.06% |
| Return on Equity (TTM) | 6.33% |
News Mood
-
5 revealing analyst questions from Acadia Healthcare’s Q3 2026 earnings call
08 Nov, 3:01PM
-
Acadia Healthcare Company (ACHC) Could Be 77% Undervalued Following Raised 2026 Guidance
07 Nov, 6:21PM
-
Acadia Healthcare Co Inc (ACHC) Q3 2026 Earnings Call Highlights: Revenue Tops $895 Million as ...
05 Nov, 5:14PM
AIStockmoo Score
| Value 30% | -2.8 |
| From our AI Insight report's view of expected return against risk. info | NA |
| Priced high for its earnings growth. info | |
| Implied Growth info | NA |
| Valuation History info | NA |
| Low debt. Thin short-term liquidity. Negative cash flow. info | |
| Return on Capital info | NA |
| Timing 30% | 3.8 |
| From our AI technical analysis of the chart. info | NA |
| Uptrend over the past year. Trading near its 52-week high. info | |
| In an uptrend: the price is above its moving averages, and they are rising. It has risen well above them. Volume is heavier on up days. info | |
| Recent bearish reversal pattern: Bearish engulfing. info | |
| Above its medium-term trend line. info | |
| Sentiment 20% | 1.1 |
| No recent price targets, so based on how targets have been revised. info | |
| Recent news mostly positive. info | |
| Smart Money 20% | -3.3 |
| Insider Activity info | NA |
| Institutions net -15.27% of shares in their latest 13F filings: 150 holders increased, 166 decreased (quarter to 30 Sep 2026). info | |
| Short interest -16.1% from 31 Aug to 30 Oct 2026, 11.2 days to cover (FINRA). info | |
| Market and sector conditions are favourable. | |
| Market environment cautious. info | |
| Sector outperforming the market. | |
| The pillars disagree, so the score is softened. | |
| Not in score | |
| Price is high against its 52-week average. Down over 5 years. info | |
| Trend up on all three terms. Short-term momentum rising. info | |
| Price is near resistance. Levels trending up. info | |
| Final Score | -0.12 |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (US) | Mixed | Mixed |
| Medical Care Facilities (Global) | Bullish | Mixed | |
| Stock | Acadia Healthcare Company, Inc. | Mixed | Bearish |
Similar Stocks
| Stock | Market Cap | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| ACHC | - | - | - | 1.70 |
| NIVF | - | - | - | - |
| BTMD | - | - | - | - |
| JYNT | - | - | - | 7.50 |
| AIRS | - | - | - | 0.500 |
| DCGO | - | - | - | 0.210 |
Select this tab to load the latest available analysis.
|
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Investment Style | Small Value |
| % Held by Insiders | 1.75% |
| % Held by Institutions | 109.93% |
No data within this time range.
No data within this time range.
Institutions
Institutional ownership: 151.24%
| Positions | Holders | Shares |
|---|---|---|
| Increased | 150 | 16,933,579 |
| Decreased | 166 | 27,387,809 |
| New | 45 | 4,680,381 |
| Sold out | 62 | 8,423,202 |
SEC 13F filings via Nasdaq, latest filings up to 30 Sep 2026. Filings arrive up to 45 days after each quarter.
Short Interest
| Settlement | Shares | Days to cover |
|---|---|---|
| 30 Oct 2026 | 18,952,887 | 11.2 |
| 15 Oct 2026 | 20,939,393 | 13.7 |
| 30 Sep 2026 | 22,770,844 | 13.9 |
| 15 Sep 2026 | 21,509,968 | 18.8 |
| 31 Aug 2026 | 22,583,163 | 12.7 |
| 14 Aug 2026 | 20,952,409 | 12.5 |
FINRA short interest via Nasdaq, reported twice a month.
| Date | Type | Details |
|---|---|---|
| 10 Nov 2026 | Yahoo Finance |
What Makes Acadia Healthcare (ACHC) a Strong Momentum Stock: Buy Now?
Does Acadia Healthcare (ACHC) have what it takes to be a top stock pick for momentum investors? Let's find out. |
| 08 Nov 2026 | Yahoo Finance |
5 revealing analyst questions from Acadia Healthcare’s Q3 2026 earnings call
Acadia Healthcare’s third quarter results drew a significant positive market reaction, as the company surpassed Wall Street’s revenue and profit expectations. Management attributed the performance to strong growth in patient volumes, effective cost controls, and accelerated operational milestones… |
| 07 Nov 2026 | Yahoo Finance |
Acadia Healthcare Company (ACHC) Could Be 77% Undervalued Following Raised 2026 Guidance
Acadia Healthcare Company (ACHC) has raised its full year 2026 revenue guidance to a range of US$3.44b to US$3.46b after reporting third quarter sales of US$895.31m. That raised outlook has coincided with a sharp move in the market. Acadia Healthcare Company’s share price has climbed 23.5% over the… |
| 07 Nov 2026 | Yahoo Finance |
Acadia Healthcare (ACHC) Stock May Still Sit Below Fair Value Following Raised 2026 Guidance
Acadia Healthcare Company has rallied hard in 2026, and the surge has pushed a simple question to the front of the queue for investors who care about valuation. After such a sharp move, the key issue is whether the current share price lines up with what the business is generating in sales. The… |
| 06 Nov 2026 | Yahoo Finance |
Is Acadia Healthcare (ACHC) Stock Outpacing Its Medical Peers This Year?
Here is how Acadia Healthcare (ACHC) and Aclaris Therapeutics (ACRS) have performed compared to their sector so far this year. |
| 06 Nov 2026 | Yahoo Finance |
Acadia Healthcare Company, Inc. (ACHC) Hit a 52 Week High, Can the Run Continue?
Acadia Healthcare (ACHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues. |
| 05 Nov 2026 | Yahoo Finance |
Acadia Healthcare Co Inc (ACHC) Q3 2026 Earnings Call Highlights: Revenue Tops $895 Million as ...
Acadia Healthcare Co Inc (ACHC) beat Q3 2026 expectations with 5.1% revenue growth, raised full-year guidance for the third straight quarter, and outlined a $60 million EBITDA step-up for 2027… |
| 05 Nov 2026 | Yahoo Finance |
Acadia Healthcare (ACHC) Q3 2026 Earnings Call Transcript
Guidance rises again as new facilities ramp up and losses shrink. |
| 05 Nov 2026 | Yahoo Finance |
Acadia Healthcare Q3 Earnings Call Highlights
Acadia Healthcare (NASDAQ:ACHC) raised its full-year 2026 financial guidance for the third consecutive quarter after reporting third-quarter revenue growth and stronger-than-expected adjusted earnings, executives said on the company’s earnings call. Revenue rose 5.1% from a year earlier to $895 mil… |
| 05 Nov 2026 | Yahoo Finance |
Acadia Healthcare Company, Inc. Q3 2026 Earnings Call Summary
Moby summary of Acadia Healthcare Company, Inc.'s Q3 2026 earnings call… |
| 04 Nov 2026 | Yahoo Finance |
Acadia Healthcare (ACHC) Surpasses Q3 Earnings and Revenue Estimates
Acadia Healthcare (ACHC) delivered earnings and revenue surprises of +30.44% and +3.00%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock? |
| 04 Nov 2026 | Yahoo Finance |
Acadia Healthcare: Q3 Earnings Snapshot
(ACHC) on Wednesday reported third-quarter earnings of $34.On a per-share basis, the Franklin, Tennessee-based company said it had profit of 38 cents. |
| 04 Nov 2026 | Yahoo Finance |
Acadia Healthcare (NASDAQ:ACHC) exceeds Q3 2026 expectations, full-year outlook slightly exceeds expectations
Behavioral health company Acadia Healthcare (NASDAQ:ACHC) beat Wall Street’s revenue expectations in Q3 2026, with revenue up 5.1% year on year to $895.3 million. The company’s full-year revenue guidance of $3.45 billion at the midpoint came in 0.6% above analysts’ consensus estimates. Its non-GAAP… |
| 04 Nov 2026 | Yahoo Finance |
Acadia Healthcare Announces Third Quarter 2026 Results and Raises Full Year 2026 Financial Guidance
FRANKLIN, Tenn., November 04, 2026--Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ: ACHC) today announced financial results for the third quarter ended September 30, 2026… |
| 03 Nov 2026 | Yahoo Finance |
Can Acadia Healthcare Company, Inc. (ACHC) Protect Its Business From AI Disruption?
Greenlight Capital, an investment management firm, recently released its Q3 2026 investor letter. A copy of the letter can be downloaded here. The funds returned -3.3% in the third quarter of 2026, compared with a 2.3% gain for the S&P 500, bringing their year-to-date return to -1.5% against the… |
| 02 Nov 2026 | Yahoo Finance |
Acadia Healthcare to Participate in November Investor Conferences
FRANKLIN, Tenn., November 02, 2026--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in two investor conferences in November. |
| 30 Oct 2026 | Yahoo Finance |
Edwards' Q3 Earnings on the Horizon: What's in the Cards?
EW heads into Q3 with TAVR momentum, expanding mitral and tricuspid therapies and surgical heart growth. Can it beat earnings estimates? |
| 29 Oct 2026 | Yahoo Finance |
GRAIL Q3 Earnings Ahead: Galleri Test Adoption to Drive Growth
GRAL's Q3 earnings should have benefited from rising Galleri test adoption, expanding digital health partnerships and growing clinical evidence of cancer detection. |
| Show more | ||
Recent Signals candle patterns and EMA crosses
Technical Setup Medium
AI Technical Analysis
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |